ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GDR Genedrive Plc

2.40
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.40 2.30 2.50 2.40 2.40 2.40 14,156 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -2.53 13.04M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 2.40p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 11.85p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £13.04 million. Genedrive has a price to earnings ratio (PE ratio) of -2.53.

Genedrive Share Discussion Threads

Showing 33401 to 33418 of 33475 messages
Chat Pages: 1339  1338  1337  1336  1335  1334  1333  1332  1331  1330  1329  1328  Older
DateSubjectAuthorDiscuss
14/11/2024
10:46
Enjoy while it lasts. This will be the next MATD imho. Disastrous.
batiatus
14/11/2024
07:52
No, that's not possible. Buy back 2.00 v 2.20. Will drift today, maybe Monday or Tuesday will be around 2.10
atmysignal
14/11/2024
07:29
POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

m_night10
14/11/2024
07:14
Separately.



genedrive plc
@genedriveplc



We had a great first day at MEDICA...

Gino Miele, Patrick Breen, Claire Newton, Jonathan Dale are on the stand and ready to meet you.

Bring on Day 2!

hazl
14/11/2024
07:14
Am I alone in following FDA in the US on x?



A good way to keep up with what's going on generally .

imo

hazl
13/11/2024
18:11
the NHS has a massive reputation in the medical world, and their experience with our product will be filtering around the world.
petersmith6
13/11/2024
16:23
Told you it was a pump and dump.
Batiatus is right once again.
I hope no one was naive enough to get sucked in. (But anyone did have themselves to blame)

This is a no profit company, just pure speculation. There is not even a debate about it. If they have concrete news then just release it.

The companies fundamentals have not changed one bit. Monthly cash burn is still £400-600K. There have been no other sales besides the £100K 9 months ago.

The directors cannot expect to sit around all day taking a salary without providing any value to shareholders.

They need to prove the kits can sell and start making some profit.

As things stand, it's just a weeks after weeks without sales, only cash burn.

The only thing that is coming is a fundraise.

(G)enuinely (D)on't (R)ecommend

batiatus
13/11/2024
15:53
The question is, did the foreskin Batty make any money today?I did!
premium beeks
13/11/2024
15:22
signal - thanks for the advice.

I've sold the lot and will get back in again at 5p!!!!!!!

eggbaconandbubble
13/11/2024
15:07
Pity the Dow doesn't look so healthy out in the US.
Seems to have stifled momentum.
However news usually revives.
Come on GDR an RNS please!

hazl
13/11/2024
14:38
POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 155p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

m_night10
13/11/2024
13:51
So just as an observation for anyone new to this game,
if you are wanting to buy a stock, sometimes lunch time is a good time. People look at stocks over their lunch hour, especially if they work and possibly take profits.
It can soften the price.
But I am not encouraging people to buy anything just trying to pass on a few things
I have noticed over the years.
When there are announcements people often rush in first thing, not neccessarily the best time to buy.


IMO

hazl
13/11/2024
11:18
You don't get an introduction to a clinic and leaflets given out to visitors
unless they are seious about a test I'm sure.
The beauty of it will be if it's rolled out in the NHS everywhere.
Then onto the US!

hazl
13/11/2024
11:15
There's often a lull on a rising share at this sort of time in my experience.
Lunch time also.

But after 3pm it tends to remain in the direction it is headed.

IMO

hazl
13/11/2024
11:09
Take profit fellas.Going back to 2.10 v 2.20
atmysignal
13/11/2024
10:37
Would like to see it make an assault to 4's for consolidation, before the next push north from there, GLA
lawson27
13/11/2024
10:13
Back to big volume again.
premium beeks
13/11/2024
08:54
A no profit company, just pure speculation. There is not even a debate here. If they have concrete news then just release it.

The companies fundamentals have not changed one bit. Monthly cash burn is still £400-600K. There have been no other sales besides the £100K 9 months ago.

The directors cannot expect to sit around all day taking a salary without providing any value to shareholders.

They need to prove the kits can sell and start making some profit.

As things stand, it's just a weeks after weeks without sales, only cash burn.

The only thing that is coming is a fundraise.

(G)enuinely (D)on't (R)ecommend

batiatus
Chat Pages: 1339  1338  1337  1336  1335  1334  1333  1332  1331  1330  1329  1328  Older

Your Recent History

Delayed Upgrade Clock